Expand PDSB Menu
PDSB MENU

PDSB Stock Posts


Unusual Option Volume

PDSB PDS Biotechnology1.12+0.19 (+20.0%)

PDS Biotechnology trades 2,245 contracts. The company has the following event: Meeting with FDA to Explore Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer on Oct 29, 2025. News: PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
$PDSB Earnings August 13 BMO. Expected Move ±7.5% vs Prev. Move +3.1%
Unusual Option Volume

PDSB PDS Biotechnology3.73-0.75 (-16.7%)

$PDSB Earnings March 27 BMO. 19-Apr-24 Straddle Implies ±25.1% Move vs Prev. Move +18.6%
Unusual Option Volume

PDSB PDS Biotechnology6.36-0.17 (-2.6%)

PDS Biotechnology trades 2,497 contracts. The company has the following event: Post-ASCO Conference Call on Jun 6, 2023.
Unusual Option Volume

PDSB PDS Biotechnology6.14-3.28 (-34.8%)

PDS Biotechnology trades 5,428 contracts. The company has the following event: 2023 American Society of Clinical Oncology (ASCO) Annual Meeting on Jun 5, 2023.
Market Data Delayed 15 Minutes